Seagen Requests Director Review Of Unpatentability Decision

On February 14, 2024, Seagen requested director review of the PTAB's January 16th Final Written Decision ("FWD") in PGR2021-00030 finding antibody-drug conjugate claims in U.S. Patent No. 10,808,039...

Related Keywords

April Breyer Menon , Seagen Adcetris , , Final Written Decision , Final Written Decision Finding , Mondaq , Seagen Requests Director Review Of Unpatentability Decision In Adcetris Xae Patent Pgr , Intellectual Property , Patent ,